AUS Edition 
NZ Edition 
UK Edition 
CA Edition 
USA Edition 
FRA Edition 
GER Edition 
ESP Edition 
ITA Edition 
NLD Edition 
PRT Edition 
SWE Edition 
GRC Edition 
IND Edition 
POL Edition 
BRA Edition 
ZAF Edition 
RUS Edition 
CHN Edition 
UAE Edition 
⚠
✓
STRATA Skin Sciences Inc (NASDAQ:SSKN)
2.33 USD
+0.020 0.866%Sponsored Reports
Loading...
| Previous Close (in USD) | 2.31 |
|---|---|
| Change | +0.020 0.866% |
| 52 W H/L (in USD) | 1.040/0.262 |
| EBITDA (in USD) | -0.767M |
| PE Ratio | -- |
| Volume | 5706 |
| Diluted Eps TTM | -0.33 |
| Total Assets (in USD) | 42.016M |
|---|---|
| Total Liabilities (in USD) | 29.328M |
| Revenue TTM (in USD) | 33.358M |
| Cash (in USD) | 8.118M |
| Market Cap (in USD) | 13.534 M |
| Revenue Per Share TTM | 0.955 |
| Gross Profit TTM (in USD) | 19.85M |
Summary
Income Statement
Balance Sheet
Change in Cash
Operating Cash
STRATA Skin Sciences Inc
STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment. The company products include XTRAC and Pharos excimer lasers, and VTRAC lamp systems for the treatment systems that are used for the treatment of psoriasis, vitiligo, and other skin conditions. It also offers TheraClear Acne Therapy System for the treatment of mild to moderate inflammatory, comedonal, and pustular acne. The company was formerly known as MELA Sciences, Inc and changed its name to STRATA Skin Sciences, Inc. in January 2016. STRATA Skin Sciences, Inc. was incorporated in 1989 and is based in Horsham, Pennsylvania.
5 Walnut Grove Drive, Horsham, PA, United States, 19044
215 619 3200
Employees: 99
Key Executives
| Sr. No. | Name | Title | Year Born |
|---|---|---|---|
| 1. | Mr. Nikolai Kabelev | VP of R&D | 1976 |
| 2. | Mr. William D. Humphries M.B.A. | Exec. Chairman | 1966 |
| 3. | Mr. Robert J. Moccia | Pres, CEO & Director | 1959 |
| 4. | Mr. Christopher Lesovitz | Chief Financial Officer | 1982 |
| 5. | Mr. Jay Sturm | Gen. Counsel & Corp. Sec. | 1956 |
| 6. | Keith Simeone | VP of Sales | NA |
| 7. | Dr. Darrell S. Rigel | Chief Medical Advisor | 1951 |
| 8. | Mr. Shmuel Gov | Exec. VP & GM | NA |
| 9. | Mr. Michael E. Goodman | Head of International Sales | NA |
| 10. | Mr. Michael R. Stewart | Independent Consultant | 1957 |
Peers
Sector: Healthcare
Industry: Medical Devices
| Company | Change (USD) | Price (USD) | Trailing PE(x) | Forward PE(x) | Price Sales TTM(x) | Price to Book Value(x) | Enterprise Value to Revenue(x) | Enterprise Value to EBITDA(x) |
|
ABT
Abbott Laboratories |
+0.270 0.203% | 133.065 | 37.150 | 23.148 | 4.666 | 4.975 | 4.878 | 19.381 |
|
SYK
Stryker Corporation |
+3.600 0.959% | 375.13 | 44.070 | 24.938 | 5.509 | 6.118 | 6.050 | 25.731 |
|
MDT
Medtronic PLC |
-0.380 0.440% | 86.24 | 26.600 | 15.873 | 3.354 | 2.083 | 3.897 | 14.117 |
|
BSX
Boston Scientific Corp |
+1.060 1.046% | 101.45 | 68.170 | 24.570 | 5.855 | 4.265 | 6.462 | 26.799 |
Income Statement
(Currency in USD)| Breakdown | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 | 31-12-2018 |
|---|---|---|---|---|---|
| Income Before Tax | -5.486M | -2.672M | -4.137M | -3.939M | -4.297M |
| Minority Interest | - | - | - | - | - |
| Net Income | -5.549M | -2.706M | -4.412M | -3.79M | -4.033M |
| Selling General Administrative | 10.087M | 9.712M | 7.898M | 10.275M | 8.786M |
| Gross Profit | 21.768M | 19.85M | 14.134M | 20.27M | 17.12M |
| Reconciled Depreciation | 5.688M | 4.086M | 3.911M | 4.821M | 5.397M |
| Ebit | -4.56M | -4.402M | -4.076M | -2.596M | -3.355M |
| Ebitda | 1.128M | -0.301M | -0.165M | 2.225M | 2.042M |
| Depreciation And Amortization | 5.688M | 4.101M | 3.911M | 4.821M | 5.397M |
| Operating Income | -4.56M | -4.402M | -4.076M | -2.596M | -3.355M |
| Other Operating Expenses | 40.81M | 34.379M | 27.166M | 34.596M | 33.21M |
| Interest Expense | 0.926M | 0.314M | -0.061M | -0.515M | 0M |
| Tax Provision | 0.063M | 0.034M | 0.275M | -0.149M | -0.264M |
| Interest Income | 0.089M | 0.015M | - | 0.515M | 1.142M |
| Net Interest Income | -0.837M | -0.299M | -0.061M | -0.515M | -1.142M |
| Income Tax Expense | 0.063M | 0.034M | 0.275M | -0.149M | -0.264M |
| Total Revenue | 36.161M | 29.977M | 23.09M | 31.586M | 29.855M |
| Total Operating Expenses | 26.417M | 24.252M | 18.21M | 23.28M | 20.475M |
| Cost Of Revenue | 14.393M | 10.127M | 8.956M | 11.316M | 12.735M |
| Total Other Income Expense Net | -0.926M | 1.73M | -0.061M | -1.343M | 0.2M |
| Net Income From Continuing Ops | -5.549M | -2.706M | -4.412M | -3.79M | -4.033M |
| Net Income Applicable To Common Shares | - | -2.706M | -4.412M | -3.597M | -2.909M |
Balance Sheet
(Currency in USD)| Breakdown | 31-12-2023 | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 |
|---|---|---|---|---|---|
| Total Assets | 42.016M | 52.272M | 46.593M | 46.778M | 47.343M |
| Intangible Assets | 7.319M | 17.394M | 10.083M | 6.345M | 7.955M |
| Other Current Assets | 0.312M | 0.691M | 0.462M | 0.331M | 0.513M |
| Total Liab | 29.328M | 30.441M | 21.179M | 20.886M | 18.69M |
| Total Stockholder Equity | 12.688M | 21.831M | 25.414M | 25.892M | 28.653M |
| Other Current Liab | 6.359M | 6.868M | 6.377M | 4.69M | 5.134M |
| Common Stock | 0.035M | 0.035M | 0.034M | 0.034M | 0.033M |
| Capital Stock | 0.035M | 0.035M | 0.034M | 0.034M | 0.034M |
| Retained Earnings | -238.058M | -227.228M | -221.679M | -218.973M | -214.561M |
| Good Will | 6.519M | 8.803M | 8.803M | 8.803M | 8.803M |
| Other Assets | - | - | 0.216M | 1.27M | 0.347M |
| Cash | 8.118M | 5.434M | 12.586M | 10.604M | 8.129M |
| Cash And Equivalents | - | - | - | - | - |
| Total Current Liabilities | 12.174M | 13.426M | 12.802M | 18.838M | 17.434M |
| Current Deferred Revenue | 2.12M | 2.778M | 3.285M | 2.262M | 2.832M |
| Net Debt | 7.515M | 3.007M | -4.557M | 0.278M | 0.537M |
| Short Term Debt | 0.352M | 0.355M | 0.318M | 9.122M | 7.588M |
| Short Long Term Debt | - | - | - | 8.753M | 7.275M |
| Short Long Term Debt Total | 15.633M | 8.441M | 8.029M | 10.882M | 8.666M |
| Other Stockholder Equity | 250.711M | 249.024M | 247.059M | 244.831M | 243.18M |
| Property Plant Equipment | - | - | 7.521M | 6.517M | 5.369M |
| Total Current Assets | 15.543M | 17.504M | 19.97M | 24.831M | 23.555M |
| Long Term Investments | - | - | - | - | - |
| Short Term Investments | - | - | - | - | - |
| Net Receivables | 4.44M | 4.471M | 3.433M | 2.944M | 4.386M |
| Long Term Debt | 15.044M | 7.476M | 7.319M | 1.05M | - |
| Inventory | 2.673M | 5.547M | 3.489M | 3.444M | 3.027M |
| Accounts Payable | 3.343M | 3.425M | 2.822M | 2.764M | 1.88M |
| Accumulated Other Comprehensive Income | 0M | - | - | - | -13.532M |
| Non Currrent Assets Other | 0.231M | 0.098M | 0.216M | 0.282M | 0.347M |
| Non Current Assets Total | 26.473M | 34.768M | 26.623M | 21.947M | 23.788M |
| Capital Lease Obligations | 0.589M | 0.965M | 0.71M | 1.079M | 1.391M |
| Long Term Debt Total | - | - | - | 1.05M | - |
Cash Flow
(Currency in USD)| Breakdown | 31-12-2023 | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 |
|---|---|---|---|---|---|
| Investments | -4.681M | -4.183M | -7.126M | -2.159M | -2.791M |
| Total Cashflows From Investing Activities | - | - | -7.126M | -2.159M | -2.791M |
| Total Cash From Financing Activities | 6.861M | -0.5M | 0.092M | 2.546M | 11.307M |
| Net Income | -10.83M | -5.549M | -2.706M | -4.412M | -4.033M |
| Change In Cash | 1.323M | -5.791M | -5.526M | 2.483M | 12.418M |
| Begin Period Cash Flow | 6.795M | 12.586M | 18.112M | 15.629M | 4.069M |
| End Period Cash Flow | 8.118M | 6.795M | 12.586M | 18.112M | 16.487M |
| Total Cash From Operating Activities | -0.519M | -1.108M | 1.508M | 2.096M | 2.896M |
| Depreciation | 5.902M | 5.688M | 4.086M | 3.911M | 5.397M |
| Other Cashflows From Investing Activities | - | - | - | -2.133M | -2.676M |
| Dividends Paid | - | - | - | - | - |
| Change To Inventory | 0.689M | -1.524M | -0.045M | -0.417M | 0.215M |
| Sale Purchase Of Stock | - | - | - | 0.018M | - |
| Other Cashflows From Financing Activities | -0.042M | -0.5M | 7.867M | 5.056M | -2.336M |
| Capital Expenditures | 5.019M | 3.552M | 3.653M | 2.159M | 1.762M |
| Change In Working Capital | -0.069M | -3.069M | 0.324M | 0.596M | 0.214M |
| Other Non Cash Items | 3.295M | 0.316M | -1.851M | 0.114M | 0.717M |
| Free Cash Flow | -5.538M | -4.66M | -2.145M | -0.063M | 1.134M |
Funds
| Sr. No. | Name | Purchased On | Shares |
|---|---|---|---|
| 1. | Vanguard Total Stock Mkt Idx Inv | 1 year ago | 593248 |
| 2. | Vanguard Institutional Extnd Mkt Idx Tr | 1 year ago | 235454 |
| 3. | Perritt Ultra MicroCap | 1 year ago | 100000 |
| 4. | Fidelity Extended Market Index | 1 year ago | 87443 |
| 5. | iShares Micro-Cap ETF | 1 year ago | 40237 |
| 6. | Vanguard Instl Ttl Stck Mkt Idx Tr | 1 year ago | 21171 |
| 7. | Vanguard Instl Ttl Stk Mkt Idx InstlPls | 1 year ago | 21171 |
| 8. | Northern Trust Extended Eq Market Idx | 1 year ago | 19716 |
| 9. | NT Ext Equity Mkt Idx Fd - L | 1 year ago | 19716 |
| 10. | Fidelity Nasdaq Composite Index | 1 year ago | 17447 |
| 11. | Fidelity Series Total Market Index | 1 year ago | 13340 |
| 12. | Vanguard Balanced Index Inv | 1 year ago | 8329 |
| 13. | BlackRock Extended Mkt Composite | 1 year ago | 6179 |
| 14. | NT Ext Equity Mkt Idx Fd - NL | 1 year ago | 5652 |
| 15. | BlackRock Extended Equity Market K | 1 year ago | 5393 |
| 16. | NT Ext Equity Mkt Idx Fd - DC - NL - T2 | 1 year ago | 4539 |
| 17. | 1290 VT Micro Cap K | 1 year ago | 3895 |
| 18. | Spartan Extended Market Index Pool E | 1 year ago | 2279 |
| 19. | Northern Trust Wilshire 5000 | 1 year ago | 1683 |
| 20. | NT US Market Cap Idx Fd - L | 1 year ago | 1683 |
Institutions
| Sr. No. | Name | Purchased On | Shares |
|---|---|---|---|
| 1. | Renaissance Technologies Corp | 1 year ago | 1067453 |
| 2. | Vanguard Group Inc | 1 year ago | 858202 |
| 3. | Goldman Sachs Group Inc | 1 year ago | 132058 |
| 4. | Geode Capital Management, LLC | 1 year ago | 110621 |
| 5. | Creative Planning Inc | 1 year ago | 100160 |
| 6. | Perritt Capital Management Inc. | 1 year ago | 100000 |
| 7. | BlackRock Inc | 1 year ago | 97436 |
| 8. | We Are One Seven, LLC | 1 year ago | 71420 |
| 9. | Chicago Partners Investment Group LLC | 1 year ago | 64223 |
| 10. | Northern Trust Corp | 1 year ago | 27170 |
| 11. | State Street Corporation | 1 year ago | 11450 |
| 12. | Tower Research Capital LLC | 1 year ago | 10798 |
| 13. | Carmichael Hill & Associates Inc | 1 year ago | 3000 |
| 14. | JPMorgan Chase & Co | 1 year ago | 634 |
| 15. | Morgan Stanley - Brokerage Accounts | 1 year ago | 510 |
| 16. | Royal Bank of Canada | 1 year ago | 320 |
| 17. | Wells Fargo & Co | 1 year ago | 167 |
| 18. | Hanson Mcclain Inc | 1 year ago | 53 |
| 19. | Nantahala Capital Management, LLC | 1 year ago | 6256264 |
| 20. | 22NW, LP | 1 year ago | 5369954 |
Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peertrades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).
Sponsored Articles
Loading...
Related Articles
Loading...